Skip to main content
Year archive

Bio Solution Co.,Ltd. — 2025 filings

All 33 regulatory filings released by Bio Solution Co.,Ltd. (086820) in 2025, sourced directly from the official regulator.

33 Filings
2025 Period
2025 filings (33)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2025-12-16 Korean
투자판단관련주요경영사항(임상시험계획승인신청) (동종 연골세포 스페로이드(스페로큐어)의 제1/2a상 임상시험계획 승인신청)
Regulatory Filings
2025-11-10 Korean
투자판단관련주요경영사항(임상시험계획승인신청) (펠렛형 동종 연골세포치료제(카티로이드)의 호주 제1/2상 임상시험계획 승인신청)
Regulatory Filings
2025-09-17 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-08-25 Korean
반기보고서 (2025.06)
Interim / Quarterly Report H1 2025
2025-08-14 Korean
금전대여결정
Capital/Financing Update
2025-07-01 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-06-05 Korean
투자판단관련주요경영사항 (펠렛형 동종 연골세포치료제(카티로이드)의 제1/2상 임상시험계획 승인신청 반려)
Legal Proceedings Report
2025-06-05 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-05-30 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2025-05-29 Korean
권리락 (무상증자)
Share Issue/Capital Change
2025-05-26 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Q1 2025
2025-05-15 Korean
주권매매거래정지 (무상증자)
Share Issue/Capital Change
2025-05-13 Korean
주요사항보고서(무상증자결정)
Share Issue/Capital Change
2025-05-13 Korean
주주명부폐쇄기간또는기준일설정
Share Issue/Capital Change
2025-05-13 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-05-09 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-05-09 Korean
투자판단관련주요경영사항(임상시험결과) (카티라이프(바솔자가연골유래연골세포치료제)의 미국 2상 임상시험 최종결과보고서 수령)
Regulatory Filings
2025-05-07 Korean
투자판단관련주요경영사항 (카티라이프(바솔자가연골유래연골세포)의 한국 식품의약품안전처 품목 변경허가 획득)
Regulatory Filings
2025-04-29 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2025-03-28 Korean
[기재정정]사업보고서 (2024.12)
Annual Report FY 2024
2025-03-28 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2025-03-28 Korean
감사보고서제출
Audit Report / Information FY 2024
2025-03-20 Korean
사업보고서 (2024.12)
Audit Report / Information FY 2024
2025-03-20 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2025-03-18 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2025-03-13 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2025-03-13 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2025-03-13 Korean
주주총회집중일개최사유신고
AGM Information
2025-03-13 Korean
투자판단관련주요경영사항(임상시험결과) (카티라이프(바솔자가연골유래연골세포)의 제3상 최종 임상시험결과보고서 수령)
Legal Proceedings Report
2025-03-05 Korean
투자판단관련주요경영사항(임상시험계획승인신청)
Regulatory Filings
2025-02-18 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2024
2025-02-13 Korean
기업설명회(IR)개최
Report Publication Announcement
2025-01-23 Korean